beta Carotene - Therapeutic use
Research News and Information

Monday, November 23, 2009

Effect of homocysteine-lowering treatment with folic Acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial.

31 May 2009 OBJECTIVE: Homocysteinemia may play an etiologic role in the pathogenesis of type 2 diabetes by promoting oxidative stress, systemic inflammation, and endothelial dysfunction. We investigated whether homocysteine-lowering treatment by B vitamin ... Read more...

Development of dietary phytochemical chemopreventive agents: biomarkers and choice of dose for early clinical trials.

24 May 2009 In view of safety concerns surrounding the use of pharmaceuticals such as nonsteroidal anti-inflammatory drugs and tamoxifen as cancer chemopreventive agents, potentially innocuous phytochemicals derived from the diet are considered attractive ... Read more...

Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: The Women's Antioxidant and Cardiovascular Study.

16 May 2009 BACKGROUND: Cardiovascular factors are associated with cognitive decline. Antioxidants may be beneficial. METHODS AND RESULTS: The Women's Antioxidant Cardiovascular Study was a trial of vitamin E (402 mg every other day), beta carotene (50 mg every ... Read more...

Latest indexed articles for 'beta Carotene - Therapeutic use'

These are the very latest articles for this heading:

• Effect of homocysteine-lowering treatment with folic Acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial. 31 May 2009
• Development of dietary phytochemical chemopreventive agents: biomarkers and choice of dose for early clinical trials. 24 May 2009
• Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: The Women's Antioxidant and Cardiovascular Study. 16 May 2009
• A systematic review of treatment options for dermal photosensitivity in erythropoietic protoporphyria. 14 Feb 2009
• Association of variants in two vitamin e transport genes with circulating vitamin e concentrations and prostate cancer risk. Feb 2009
• Antioxidants: not for prevention. 30 Jan 2009
• [Established therapies for skin diseases. Vitamins in dermatology.] 30 Dec 2008
• Effect of beta-carotene-rich tomato lycopene beta-cyclase ( tlcy-b) on cell growth inhibition in HT-29 colon adenocarcinoma cells. 22 Dec 2008
• Vitamin and mineral use and risk of prostate cancer: the case-control surveillance study. 16 Dec 2008
• Antioxidant vitamins and the risk of endometrial cancer: a dose-response meta-analysis. 14 Dec 2008
• Reduction of micronuclei in oral lichen planus supplemented with beta-carotene. 29 Nov 2008
• Beta-carotene in dermatology: Does it help? 29 Nov 2008
• Anti-adult T-cell leukemia effects of brown algae fucoxanthin and its deacetylated product, fucoxanthinol. 29 Nov 2008
• A 9-cis beta-carotene-enriched diet inhibits atherogenesis and fatty liver formation in LDL receptor knockout mice. 29 Sep 2008
• Glycaemic index database for the epidemiological Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study. 23 Sep 2008
• Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease. Jul 2008
• IGF-I, IGFBP-3, and IGF-I/IGFBP-3 ratio: no association with incident colorectal cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. 29 Jun 2008
• An antioxidant turnabout. 30 May 2008
• Dietary supplementation by Japanese patients with chronic obstructive pulmonary disease. 16 Apr 2008
• Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and meta-analysis. 16 Apr 2008

See a longer list of these articles.

Technical information about 'beta Carotene'

Definition: A carotenoid that is a precursor of VITAMIN A. It is administered to reduce the severity of photosensitivity reactions in patients with erythropoietic protoporphyria (PORPHYRIA, ERYTHROPOIETIC). (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Engewood, CO, 1995.)

Registry Number: 7235-40-7

Descriptor UI: D019207

Alternative terms: beta Carotene; Carotene, beta; Betacarotene; beta-Carotene; Max-Caro; Max Caro; MaxCaro; Marlyn Brand of Betacarotene; Betacarotene Marlyn Brand; Provatene; Solgar Brand of Betacarotene; Betacarotene Solgar Brand; BellaCarotin; 3M Brand of Betacarotene; Betacarotene 3M Brand; Vetoron; Carotaben; Merck Brand of Betacarotene; Betacarotene Merck Brand; Hermal Brand of Betacarotene; Betacarotene Hermal Brand; Solatene; Roche Brand of Betacarotene; Betacarotene Roche Brand;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Pharmacological Action: Vitamins;

Tree Number: D02.455.326.271.665.202.123; D02.455.426.392.368.367.379.249.050; D02.455.849.131.123; D23.767.261.050;

Online Note: use BETA CAROTENE (NM) to search BETA-CAROTENE 1980-96

History Note: 97; was BETA-CAROTENE (NM) 1980-96